Literature DB >> 28821358

On the brink of precision medicine for psychosis: Treating the patient, not the disease: A commentary on: Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment by Krivoy et al. 2017.

Arsime Demjaha1.   

Abstract

Entities:  

Keywords:  Biomarkers; Clozapine; Precision medicine; Psychosis; Treatment resistant schizophrenia

Mesh：

Substances：

Year:  2017        PMID： 28821358     DOI： 10.1016/j.schres.2017.08.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  2 in total

1.  The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia.

Authors:  Ilinca Angelescu; Stephen J Kaar; Tiago Reis Marques; Faith Borgan; Mattia Veronesse; Alice Sharman; Anil Sajjala; Bill Deakin; John Hutchison; Charles Large; Oliver D Howes
Journal:  J Psychopharmacol       Date:  2022-09       Impact factor: 4.562

Review 2.  Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?

Authors:  Jan Scott; Bruno Etain; Frank Bellivier
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.